LPCAT2 and chronic rhinosinusitis with nasal polyps: Therefore, these results support the idea that PAF-metabolism-associated gene expression, especially in combination with LPCAT1 and LPCAT2 gene expression, can become a biomarker for the severity of type 2 inflammation in CRSwNP and may add other insights for strategies of biologic therapy initiation and selection in CRSwNP [32].